Alexza Pharma (ALXA) Resumes, Shares Move Lower
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Alexza Pharma (ALXA) to resume trading at 4:15pm ET
December 21, 2012 3:31 PM ESTAlexza Pharma (NASDAQ: ALXA) to resume trading at 4:15pm EST.... More
FDA Approves Alexza's (ALXA) Adusave
December 21, 2012 3:28 PM ESTAlexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced today that the U.S. Food and Drug Administration (FDA) approved ADASUVE® (loxapine) Inhalation Powder 10 mg for the acute treatment of agitation associated with schizophrenia or bipolar I disorder in adults. ADASUVE combines Alexza's proprietary Staccato® delivery system with the antipsychotic drug, loxapine. The Staccato system is a hand-held inhaler that delivers a drug aerosol to the deep lung that results in rapid systemic delivery and absorption of a drug. See below for Important Safety Information about ADASUVE, including Boxed Warnings.
... More
Alexza Pharma (ALXA) trading halted with news pending
December 21, 2012 2:40 PM ESTAlexza Pharma (NASDAQ: ALXA) trading halted with news pending.... More
Sentiment Behind FDA Approval of Alexza's (ALXA) Adusave Improves; Shares Higher Today
December 20, 2012 12:31 PM ESTAlexza Pharmaceuticals (Nasdaq: ALXA) is higher on the session amid positive sentiment behind its Adasuve receiving FDA approval tomorrow.
Last week, Alexza reported that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a... More
